BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 36 filers reported holding BRIDGEBIO PHARMA INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $5,891 | -63.6% | 5,499,000 | -59.0% | 0.02% | -67.2% |
| Q4 2023 | $16,188 | -99.5% | 13,396,000 | +214.7% | 0.06% | +728.6% |
| Q4 2021 | $3,138,000 | -51.7% | 4,257,000 | -9.4% | 0.01% | -56.2% |
| Q3 2021 | $6,494,000 | -12.3% | 4,698,000 | +4.0% | 0.02% | -11.1% |
| Q2 2021 | $7,408,000 | +4.8% | 4,517,000 | +5.7% | 0.02% | 0.0% |
| Q1 2021 | $7,068,000 | – | 4,272,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 143,338,000 | $106,213,458 | 3.50% |
| ARISTEIA CAPITAL, L.L.C. | 167,448,000 | $124,078,968 | 2.91% |
| Affinity Asset Advisors, LLC | 10,000,000 | $7,410,000 | 2.44% |
| CONTRARIAN CAPITAL MANAGEMENT, L.L.C. | 8,500,000 | $6,256,000 | 1.62% |
| TFG Asset Management GP Ltd | 10,000,000 | $7,473,611 | 1.00% |
| Context Capital Management, LLC | 14,785 | $10,956 | 0.92% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 30,329,000 | $22,670 | 0.83% |
| Weiss Asset Management LP | 7,500,000 | $5,582,792 | 0.36% |
| CSS LLC/IL | 6,600,000 | $4,887,815 | 0.32% |
| MACKAY SHIELDS LLC | 14,404,000 | $10,673,364 | 0.29% |